Cargando…
Exposure of Mesenchymal Stem Cells to an Alzheimer's Disease Environment Enhances Therapeutic Effects
Mesenchymal stem cells (MSCs) have emerged as a promising tool for the treatment of Alzheimer's disease (AD). Previous studies suggested that the coculture of human MSCs with AD in an in vitro model reduced the expression of amyloid-beta 42 (Aβ42) in the medium as well as the overexpression of...
Autores principales: | Park, Sang Eon, Kim, Hyeong Seop, Kwon, Soo Jin, Kim, Min-Jeong, Choi, Suk-joo, Oh, Soo-young, Ryu, Gyu Ha, Jeon, Hong Bae, Na, Duk L., Chang, Jong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988745/ https://www.ncbi.nlm.nih.gov/pubmed/33815510 http://dx.doi.org/10.1155/2021/6660186 |
Ejemplares similares
-
Pressure Stimuli Improve the Proliferation of Wharton’s Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions
por: Park, Sang Eon, et al.
Publicado: (2020) -
Anti-Fibrotic Effect of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1
por: Choi, Alee, et al.
Publicado: (2020) -
Wharton's Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
por: Kim, Sun Jeong, et al.
Publicado: (2022) -
Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer’s Disease Model
por: Lee, Na Kyung, et al.
Publicado: (2017) -
Wharton’s Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499
por: Park, Sang Eon, et al.
Publicado: (2021)